208 related articles for article (PubMed ID: 679196)
41. Immunogenicity of cyclophosphamide-treated leukaemia cells.
Kawalec M; Jakóbisiak M; Skórski T; Kawiak J
Folia Biol (Praha); 1982; 28(5):334-43. PubMed ID: 6816636
[TBL] [Abstract][Full Text] [Related]
42. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
Rose WC; Trader MW; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
[No Abstract] [Full Text] [Related]
43. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
44. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
[TBL] [Abstract][Full Text] [Related]
45. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
Mosienko VS; Khasanova LT; Sukolinskiĭ VN; Morozkina TS
Eksp Onkol; 1990; 12(3):55-7. PubMed ID: 2344827
[TBL] [Abstract][Full Text] [Related]
46. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
Schmid FA; Hutchison DJ
Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
[No Abstract] [Full Text] [Related]
47. [Carminomycin induction of single-stranded breaks in the DNA of tumor cells].
Trenin AS
Antibiotiki; 1978 May; 23(5):400-3. PubMed ID: 655684
[TBL] [Abstract][Full Text] [Related]
48. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
Burns ER; Scheving LE
Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
[No Abstract] [Full Text] [Related]
49. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
Perevodchikova NI; Lichinitser MR; Gorbunova VA
Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
[No Abstract] [Full Text] [Related]
50. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice.
Warzocha K; Robak T; Korycka A; Graczyk J; Pakulska W; Gałazka G; Kłysik J
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):587-95. PubMed ID: 1841555
[TBL] [Abstract][Full Text] [Related]
51. [Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].
Berezina TA; Uteshev BS; Babichev VS
Farmakol Toksikol; 1979; 42(5):537-41. PubMed ID: 488332
[TBL] [Abstract][Full Text] [Related]
52. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
53. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
Valeriote F; Vietti T; Coulter D
J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
[TBL] [Abstract][Full Text] [Related]
55. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ
J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
[No Abstract] [Full Text] [Related]
56. Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Lelieveld P; van Putten LM
Cancer Treat Rep; 1976 Apr; 60(4):373-9. PubMed ID: 1064468
[TBL] [Abstract][Full Text] [Related]
57. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
58. [Use of carminomycin on children and adolescents with osteogenic sarcoma].
Bizer VA
Antibiotiki; 1979 Feb; 24(2):137-40. PubMed ID: 373620
[TBL] [Abstract][Full Text] [Related]
59. [Carminomycin study in breast cancer].
Lichinitser MR; Assekritova IV; Gorbunova VA; Arseriĭ SA; Vaarik KhM
Antibiotiki; 1978 May; 23(5):453-7. PubMed ID: 350145
[TBL] [Abstract][Full Text] [Related]
60. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Ninomiya K; Sekido S; Araki T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
